Stay updated on Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    A 403 Forbidden page is displayed, replacing the study content with a minimal header and a Home link, indicating access to the record is blocked.
    Difference
    20%
    Check dated 2026-09-21T22:24:32.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    There are no additions or deletions listed for this study in the provided changes data, so the study record remains unchanged.
    Difference
    0.1%
    Check dated 2026-09-14T18:22:29.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Added dates 2026-09-01, 2025-12-31, and 2026-08-28; removed 2026-08-26, 2026-03-05, and 2026-08-24 from the Study Record Dates, reflecting updates to the record’s milestone and revision history.
    Difference
    0.3%
    Check dated 2026-09-07T19:37:04.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The study record now shows completion with updated primary completion and study completion dates, and a new page revision (v3.6.6), replacing the previous active, not recruiting status.
    Difference
    0.6%
    Check dated 2026-08-31T17:16:17.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The Study Record Dates section now shows Revision: v3.6.5, indicating a new revision of the page entry. No study details, enrollment information, or eligibility criteria appear to be altered.
    Difference
    0.1%
    Check dated 2026-08-10T16:27:01.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, signaling a new version of the page. This indicates a maintenance update without altering the study information.
    Difference
    0.1%
    Check dated 2026-07-27T06:24:21.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial page.